The Faculty Hospital in Nitra is a hospital in the city of Nitra, in western Slovakia. Its address is Špitalská 6, 950 01, Nitra. It is attached to the Constantine the Philosopher University in Nitra.

During the past decade, Fakultna Nemocnica Nitra conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fakultna Nemocnica Nitra" #1 sponsor was "Arena Pharmaceuticals" with 2 trials, followed by "Baxalta now part of Shire" with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Advanz Pharma" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultna Nemocnica Nitra" #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Fakultna Nemocnica Nitra" are "Ulcerative Colitis" (4 trials), "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "Crohn's Disease" (2 trials), "Multiple Sclerosis" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Fakultna Nemocnica Nitra" in a lesser frequency.

Most popular intervention types in "Fakultna Nemocnica Nitra" are "Drug" (15 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Etrasimod" (3 trials), "GED-0301" (2 trials), "HYQVIA" (2 trials) and "Mavenclad®" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fakultna Nemocnica Nitra" are 18 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fakultna Nemocnica Nitra". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Fakultna Nemocnica Nitra, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultna Nemocnica Nitra, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".